• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类P2Y1受体中的两个不同配体结合位点。

Two disparate ligand-binding sites in the human P2Y1 receptor.

作者信息

Zhang Dandan, Gao Zhan-Guo, Zhang Kaihua, Kiselev Evgeny, Crane Steven, Wang Jiang, Paoletta Silvia, Yi Cuiying, Ma Limin, Zhang Wenru, Han Gye Won, Liu Hong, Cherezov Vadim, Katritch Vsevolod, Jiang Hualiang, Stevens Raymond C, Jacobson Kenneth A, Zhao Qiang, Wu Beili

机构信息

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Pudong, Shanghai 201203, China.

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Nature. 2015 Apr 16;520(7547):317-21. doi: 10.1038/nature14287. Epub 2015 Mar 30.

DOI:10.1038/nature14287
PMID:25822790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408927/
Abstract

In response to adenosine 5'-diphosphate, the P2Y1 receptor (P2Y1R) facilitates platelet aggregation, and thus serves as an important antithrombotic drug target. Here we report the crystal structures of the human P2Y1R in complex with a nucleotide antagonist MRS2500 at 2.7 Å resolution, and with a non-nucleotide antagonist BPTU at 2.2 Å resolution. The structures reveal two distinct ligand-binding sites, providing atomic details of P2Y1R's unique ligand-binding modes. MRS2500 recognizes a binding site within the seven transmembrane bundle of P2Y1R, which is different in shape and location from the nucleotide binding site in the previously determined structure of P2Y12R, representative of another P2YR subfamily. BPTU binds to an allosteric pocket on the external receptor interface with the lipid bilayer, making it the first structurally characterized selective G-protein-coupled receptor (GPCR) ligand located entirely outside of the helical bundle. These high-resolution insights into P2Y1R should enable discovery of new orthosteric and allosteric antithrombotic drugs with reduced adverse effects.

摘要

对5'-二磷酸腺苷作出反应时,P2Y1受体(P2Y1R)促进血小板聚集,因此是一个重要的抗血栓药物靶点。在此,我们报告了人P2Y1R与核苷酸拮抗剂MRS2500形成复合物时分辨率为2.7 Å的晶体结构,以及与非核苷酸拮抗剂BPTU形成复合物时分辨率为2.2 Å的晶体结构。这些结构揭示了两个不同的配体结合位点,提供了P2Y1R独特配体结合模式的原子细节。MRS2500识别P2Y1R七跨膜束内的一个结合位点,其形状和位置与先前确定的P2Y12R(代表另一个P2YR亚家族)结构中的核苷酸结合位点不同。BPTU与受体外部与脂质双层的界面上的一个别构口袋结合,使其成为第一个在结构上得到表征的完全位于螺旋束外部的选择性G蛋白偶联受体(GPCR)配体。这些对P2Y1R的高分辨率见解应有助于发现副作用更小的新型正构和别构抗血栓药物。

相似文献

1
Two disparate ligand-binding sites in the human P2Y1 receptor.人类P2Y1受体中的两个不同配体结合位点。
Nature. 2015 Apr 16;520(7547):317-21. doi: 10.1038/nature14287. Epub 2015 Mar 30.
2
Distinct Signaling Patterns of Allosteric Antagonism at the P2Y Receptor.P2Y受体变构拮抗作用的独特信号模式
Mol Pharmacol. 2017 Nov;92(5):613-626. doi: 10.1124/mol.117.109660. Epub 2017 Sep 1.
3
Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y Receptor.人P2Y受体不同激动剂结合位点及激活机制的鉴定
Sci Rep. 2017 Oct 23;7(1):13764. doi: 10.1038/s41598-017-14268-1.
4
BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents.BPTU是一种P2Y1受体变构拮抗剂,可阻断啮齿动物胃肠道中神经介导的抑制性神经肌肉反应。
Neuropharmacology. 2016 Nov;110(Pt A):376-385. doi: 10.1016/j.neuropharm.2016.07.033. Epub 2016 Aug 3.
5
Agonist-bound structure of the human P2Y12 receptor.人源 P2Y12 受体激动剂结合结构。
Nature. 2014 May 1;509(7498):119-22. doi: 10.1038/nature13288.
6
Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.一种靶向血小板P2Y1受体的新型功能阻断抗体的特性研究。
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):637-44. doi: 10.1161/ATVBAHA.114.304509. Epub 2015 Jan 15.
7
The Molecular Mechanism of P2Y1 Receptor Activation.P2Y1 受体激活的分子机制。
Angew Chem Int Ed Engl. 2016 Aug 22;55(35):10331-5. doi: 10.1002/anie.201605147. Epub 2016 Jul 27.
8
Demystifying P2Y Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses.通过对接和分子动力学分析揭示 P2Y 受体配体识别的奥秘。
J Chem Inf Model. 2017 Dec 26;57(12):3104-3123. doi: 10.1021/acs.jcim.7b00528. Epub 2017 Nov 28.
9
Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500).利用 [(125)I]-标记的高亲和力拮抗剂 2-碘-N(6)-甲基-(N)-甲羰-2'-脱氧腺苷-3',5'-双磷酸 ([(125)I]MRS2500) 对重组和血小板 P2Y(1)受体进行定量。
Pharmacol Res. 2010 Oct;62(4):344-51. doi: 10.1016/j.phrs.2010.05.007. Epub 2010 Jun 4.
10
Structure of the human P2Y12 receptor in complex with an antithrombotic drug.人源 P2Y12 受体与抗血栓药物复合物的结构。
Nature. 2014 May 1;509(7498):115-8. doi: 10.1038/nature13083. Epub 2014 Mar 23.

引用本文的文献

1
Evaluation of Small-Molecule Binding Site Prediction Methods on Membrane-Embedded Protein Interfaces.膜嵌入蛋白界面小分子结合位点预测方法的评估
J Chem Inf Model. 2025 Jul 14;65(13):6949-6967. doi: 10.1021/acs.jcim.5c00336. Epub 2025 Jul 2.
2
Structural insight into the self-activation and G-protein coupling of P2Y2 receptor.P2Y2受体自激活和G蛋白偶联的结构解析
Cell Discov. 2025 May 13;11(1):47. doi: 10.1038/s41421-025-00797-x.
3
Drug-like Antagonists of P2Y Receptor Subtypes: An Update.P2Y 受体亚型的类药拮抗剂:最新进展

本文引用的文献

1
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.人源 GPR40 受体与变构激动剂 TAK-875 结合的高分辨率结构。
Nature. 2014 Sep 4;513(7516):124-7. doi: 10.1038/nature13494. Epub 2014 Jul 20.
2
Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.发现基于 4-芳基-7-羟基吲哚啉的 P2Y1 拮抗剂作为新型抗血小板药物。
J Med Chem. 2014 Jul 24;57(14):6150-64. doi: 10.1021/jm5006226. Epub 2014 Jul 7.
3
Agonist-bound structure of the human P2Y12 receptor.人源 P2Y12 受体激动剂结合结构。
J Med Chem. 2025 May 8;68(9):9057-9083. doi: 10.1021/acs.jmedchem.5c00249. Epub 2025 Apr 27.
4
E. B. Hershberg Award: Taming Inflammation by Tuning Purinergic Signaling.E.B. 赫什伯格奖:通过调节嘌呤能信号传导来控制炎症
Acc Chem Res. 2025 Mar 18;58(6):958-970. doi: 10.1021/acs.accounts.5c00011. Epub 2025 Mar 5.
5
Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation.利用残基相互作用网络和配体竞争饱和法鉴定A类G蛋白偶联受体上的可成药结合位点
ACS Omega. 2024 Sep 13;9(38):40154-40171. doi: 10.1021/acsomega.4c06172. eCollection 2024 Sep 24.
6
The microglial P2Y receptor as a therapeutic target for neurodegenerative diseases.小胶质细胞 P2Y 受体作为神经退行性疾病的治疗靶点。
Transl Neurodegener. 2024 Sep 7;13(1):47. doi: 10.1186/s40035-024-00438-5.
7
Exploring an Intracellular Allosteric Site of CC-Chemokine Receptor 4 from 3D Models, Probe Simulations, and Mutagenesis.通过三维模型、探针模拟和诱变探索CC趋化因子受体4的细胞内变构位点
ACS Pharmacol Transl Sci. 2024 Jul 16;7(8):2516-2526. doi: 10.1021/acsptsci.4c00330. eCollection 2024 Aug 9.
8
Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands.TAAR1 和 TAAR5 配体的发现和优化的计算方法。
Int J Mol Sci. 2024 Jul 27;25(15):8226. doi: 10.3390/ijms25158226.
9
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
10
Structural basis of tethered agonism and G protein coupling of protease-activated receptors.蛋白酶激活受体的束缚激动和 G 蛋白偶联的结构基础。
Cell Res. 2024 Oct;34(10):725-734. doi: 10.1038/s41422-024-00997-2. Epub 2024 Jul 12.
Nature. 2014 May 1;509(7498):119-22. doi: 10.1038/nature13288.
4
Structure of the human P2Y12 receptor in complex with an antithrombotic drug.人源 P2Y12 受体与抗血栓药物复合物的结构。
Nature. 2014 May 1;509(7498):115-8. doi: 10.1038/nature13083. Epub 2014 Mar 23.
5
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.构象限制的邻氨基苯基二芳基脲:1-(2-(1'-新戊基螺[吲哚啉-3,4'-哌啶]-1-基)苯基)-3-(4-(三氟甲氧基)苯基)脲的发现,一种强效、选择性和可生物利用的 P2Y1 拮抗剂。
J Med Chem. 2013 Nov 27;56(22):9275-95. doi: 10.1021/jm4013906. Epub 2013 Nov 12.
6
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.CCR5 趋化因子受体-人类免疫缺陷病毒进入抑制剂马拉维若复合物的结构。
Science. 2013 Sep 20;341(6152):1387-90. doi: 10.1126/science.1241475. Epub 2013 Sep 12.
7
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.发现具有改善的水溶性的二芳基脲 P2Y(1) 拮抗剂。
Bioorg Med Chem Lett. 2013 Jun 1;23(11):3239-43. doi: 10.1016/j.bmcl.2013.03.125. Epub 2013 Apr 6.
8
Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.发现 2-(苯氧基吡啶)-3-苯基脲作为小分子 P2Y1 拮抗剂。
J Med Chem. 2013 Feb 28;56(4):1704-14. doi: 10.1021/jm301708u. Epub 2013 Feb 18.
9
High-resolution crystal structure of human protease-activated receptor 1.人蛋白酶激活受体 1 的高分辨率晶体结构。
Nature. 2012 Dec 20;492(7429):387-92. doi: 10.1038/nature11701. Epub 2012 Dec 9.
10
Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) Receptor.人类P2Y(1)受体跨膜结构域内非核苷酸拮抗剂识别的证据。
Drug Dev Res. 2002 Dec 1;57(4):173-181. doi: 10.1002/ddr.10145. Epub 2003 Jan 22.